Analyst Reco. XP Inc.

Equities

XP

KYG982391099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
20.64 ^USD	+0.34%		-4.27%	-20.83%

Apr. 23	XP's Slower Business Momentum Likely to Drive Outperformance, Morgan Stanley Says	MT
Apr. 23	Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31	Apr. 23	MT
Citigroup Adjusts Price Target on XP to $29 From $28, Maintains Buy Rating	Mar. 22	MT
UBS Adjusts XP Price Target to $30 From $31, Maintains Buy Rating	Dec. 11	MT
JPMorgan Upgrades XP to Overweight From Neutral, Raises Price Target to $30 From $27	Dec. 05	MT
UBS Trims XP's Price Target to $31 From $33, Keeps Buy Rating	Nov. 06	MT
UBS Raises XP's Price Target to $33 From $28, Keeps Buy Rating	23-09-01	MT
JPMorgan Adjusts Price Target on XP to $27 From $18.50, Maintains Neutral Rating	23-08-23	MT
Citigroup Adjusts XP Price Target to $30 From $20, Maintains Buy Rating	23-08-21	MT
Credit Suisse Upgrades XP to Neutral From Underperform, Adjusts Price Target to $26 From $15	23-07-20	MT
Goldman Sachs Adjusts Price Target on XP to $29 From $22, Maintains Buy Rating	23-07-10	MT
BofA Securities Upgrades XP to Buy From Neutral	23-06-22	MT
UBS Raises XP's Price Target to $28 From $21, Maintains Buy Rating	23-06-20	MT
Bradesco BBI Downgrades XP to Neutral From Outperform, Adjusts Price Target to $17 From $25	23-05-18	MT
Goldman Sachs Adjusts Price Target on XP to $22 From $20, Maintains Buy Rating	23-05-16	MT
UBS Adjusts XP Price Target to $21 From $28, Maintains Buy Rating	23-03-31	MT
Goldman Sachs Cuts XP's Price Target to $20 From $30, Maintains Buy Rating	23-03-02	MT
HSBC Adjusts Price Target on XP to $20 From $26, Maintains Buy Rating	23-02-28	MT
Citigroup Adjusts XP Price Target to $19 From $24, Maintains Buy Rating	23-02-27	MT
Goldman Sachs Adjusts Price Target on XP to $35 From $40, Maintains Buy Rating	22-11-28	MT
Brazilian broker XP's profit gains from higher client assets	22-11-08	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. XP Inc.

Equities

XP

KYG982391099

Analyst Reco.

Filters